Local regulatory approval, availability, and reimbursement for Mounjaro may vary by country
Considering the broader genetic background, pharmacogenomic variability may further contribute to treatment heterogeneity, as genetic variants affecting GLP-1 receptor signaling, appetite regulation, insulin secretion, and hostmicrobiota interactions could influence individual responsiveness (126)
Assessment and periodic monitoring of emotional health, at least on an annual basis, is recommended to promote case-finding, emotional wellbeing and patient satisfaction with care [188, 189]
We treat obesity as a medical condition and not a personal failure
All treatment decisions are made by a prescriber based on your individual suitability
To discuss the potential role, limits, and alternatives of peptide therapy in a medically supervised setting, contact Optimal Health Medical to schedule a consultation with Dr